Spectrum Planning & Advisory Services »

Crispr Therapeutics shares owned by Spectrum Planning & Advisory Services

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Spectrum Planning & Advisory Services from 13F filings

Historical chart of Spectrum Planning & Advisory Services investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Spectrum Planning & Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Spectrum Planning & Advisory Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $221k 3.5k 62.60
2023-06-30 $207k 3.7k 56.25
2022-09-30 $249k 3.8k 65.25
2022-06-30 $238k 3.9k 60.85
2022-03-31 $310k 4.9k 62.69
2021-12-31 $375k 4.9k 75.83
2021-09-30 $503k 4.5k 111.90
2021-06-30 $740k 4.6k 161.85
2021-03-31 $570k 4.7k 121.93
2020-12-31 $700k 4.6k 153.01